Drugs formulary process (FOI)

Request

A

What is the process(es) for drugs which have a NICE Technology Appraisal?

B

What is the name of the formulary committee(s) that will be reviewing this on behalf of your organisation?

C

What are the forthcoming dates of these committee(s) meetings as far as they have been scheduled?

D

What is the name of the committee(s) Secretary and contact details?

E

What is the name of the committee(s) Chair and contact details?

F

Please provide copies of the previous two minutes from the committee(s) meetings?

G

Please provide a copy of the Terms of Reference for the committee(s)?

H

Please provide a copy of the application form which needs to be completed, where a different form is applicable for different committees, please send over each one?

Response

A

Jersey has a restricted/’white’ list of medicines (called the Prescribed List) that are available in the community at no charge to the patient. Medicines are added to this List by Ministerial decision, typically following recommendation by the Pharmaceutical Benefit Advisory Committee (PBAC). Applications to the PBAC are received from healthcare professionals in primary and secondary care and recommendations made based on consideration of evidence of quality, safety and efficacy. NICE Technology Appraisals (TA) are considered as part of this process but there is no funding mandate in Jersey primary care for medicines supported by a NICE TA. 

B

Pharmaceutical Benefit Advisory Committee (PBAC).

C

PBAC committee meetings are scheduled for:

• 9 February 2023
• 8 June 2023
• 7 September 2023
• 9 November 2023

D

Third party supplier ‘AM to PM Secretarial Services’.  Contact details are email via aimee@amtopmsecretarial.com. 

E

Professor Colette Fagan, FAcSS.  Contact details are email via aimee@amtopmsecretarial.com - marked ‘For the attention of Chair PBAC’.

F

Minutes of the Committee meetings are not subject to publication as they comprise the formulation and development of policies and publication would hinder the free and frank discussion of the subject matter. Article 35 of the Freedom of Information (Jersey) Law 2011 has been applied. 

Amendments to the prescribed list as a result of the PBAC meetings are published via a Ministerial Decision.  In respect of the last two meetings, the Ministerial Decisions can be viewed in the following links:

Prescribed List as at 1 December 2022 (gov.je)

Amendment to the Prescribed List: 1 October 2022 (gov.je)

G

Please see below:

PBAC terms of reference May 2021.pdf

H

Please see PBAC application below:

PBAC application form (revised) v1.2.pdf

Article applied

Article 35 - Formulation and development of policies

Information is qualified exempt information if it relates to the formulation or development of any proposed policy by a public authority.